• Issue

    HemaSphere: Volume 6, Issue 4

    April 2022
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Letter

Open Access

Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia

Nadine Kutsch,  Christian Pallasch,  Eugen Tausch,  Volkmar Böhme,  Matthias Ritgen,  Rüdiger Liersch,  Alexander Wacker,  Georg Jacobs,  Ralf Ulrich Trappe,  Peter Dreger,  Kirsten Fischer,  Anna-Maria Fink,  Stephan Stilgenbauer,  Shuyan Zhai,  Biao Li,  Juliane M. Jürgensmeier,  Nishanthan Rajakumaraswamy,  Pankaj Bhargava,  Michael Hallek,  Barbara F. Eichhorst, 
  • First Published: 08 March 2022

Article

Open Access

Predicting Individual Changes in Terminal Half-Life After Switching to Extended Half-Life Concentrates in Patients With Severe Hemophilia

Olav Versloot,  Emma Iserman,  Pierre Chelle,  Federico Germini,  Andrea N. Edginton,  Roger E. G. Schutgens,  Alfonso Iorio,  Kathelijn Fischer,  on behalf of the prophylaxis working group of the International Prophylaxis Study Group , 
  • First Published: 21 March 2022
Open Access

Monitoring of Leukemia Clones in B-cell Acute Lymphoblastic Leukemia at Diagnosis and During Treatment by Single-cell DNA Amplicon Sequencing

Sarah Meyers,  Llucia Alberti-Servera,  Olga Gielen,  Margot Erard,  Toon Swings,  Jolien De Bie,  Lucienne Michaux,  Barbara Dewaele,  Nancy Boeckx,  Anne Uyttebroeck,  Kim De Keersmaecker,  Johan Maertens,  Heidi Segers,  Jan Cools,  Sofie Demeyer, 
  • First Published: 10 March 2022

Perspective

Open Access

Addressing Inequality of Access to Biologics: What Is Your Role? A Patient (Advocate)’s Perspective on Biosimilars

Maria M. Piggin, 
  • First Published: 11 March 2022

Article

Open Access

External Validation of the Revised Pretransplant Assessment of Mortality Score in Allogeneic Hematopoietic Cell Transplantation: A Cohort Study

Nicolas Fattinger,  Jan A. Roth,  Helen Baldomero,  Daiana Stolz,  Michael Medinger,  Dominik Heim,  Michael Tamm,  Jörg P. Halter,  Jakob R. Passweg,  Martina Kleber, 
  • First Published: 11 March 2022

Letter

Open Access

Concurrent Composite Lymphomas Collectively Bearing Three Diagnostic Entities of Shared Clonal Origin

Waleed Alduaij,  Laura K. Hilton,  Muntadhar Al Moosawi,  Susana Ben-Neriah,  Barbara Meissner,  Merrill Boyle,  Kelly Mekwunye,  David W. Scott,  Heather A. Leitch,  Jeffrey W. Craig, 
  • First Published: 29 March 2022

Article

Open Access

Prognostic Stratification of Diffuse Large B-cell Lymphoma Using Clinico-genomic Models: Validation and Improvement of the LymForest-25 Model

Adrián Mosquera Orgueira,  Jose Ángel Díaz Arías,  Miguel Cid López,  Andrés Peleteiro Raíndo,  Alberto López García,  Rosanna Abal García,  Marta Sonia González Pérez,  Beatriz Antelo Rodríguez,  Carlos Aliste Santos,  Manuel Mateo Pérez Encinas,  Máximo Francisco Fraga Rodríguez,  José Luis Bello López, 
  • First Published: 25 March 2022

Guideline Article - Expert opinion

Open Access

Cytogenetics in Chronic Lymphocytic Leukemia: ERIC Perspectives and Recommendations

Panagiotis Baliakas,  Blanca Espinet,  Clemens Mellink,  Marie Jarosova,  Anastasia Athanasiadou,  Paolo Ghia,  Arnon P. Kater,  David Oscier,  Claudia Haferlach,  Kostas Stamatopoulos,  on behalf of ERIC, the European Research Initiative on CLL , 
  • First Published: 25 March 2022

HemaTopics

Open Access

The Next Generation of FACS – Not Just a Uniform Blob of Fluorescence

David G. Kent, 
  • First Published: 31 March 2022
Open Access

This Is Going to Hurt: Revisiting the Patient Experience of Bone Marrow Biopsies

Stephen Hibbs, 
  • First Published: 25 March 2022